Article
- Author:
- Robert L. Barbieri, MD
Publish date: September 18, 2022
The CDC recently reported that in 2019 hypertensive disorders of pregnancy (HDPs) were diagnosed in 15.9% of hospital deliveries. Does the increase...
Article
- Author:
- Robert L. Barbieri, MD
Publish date: August 9, 2022
Mifepristone is an important agent for the treatment of miscarriage and fetal demise, improving successful resolution of the pregnancy loss. Obstet...
Article
- Author:
- Robert L. Barbieri, MD
Publish date: July 13, 2022
The effect of misoprostol on uterine contraction is greatly influenced by the dose and route of administration
...
Article
- Author:
- Robert L. Barbieri, MD
Publish date: June 9, 2022
If precedents set in Roe v Wade are overturned, ObGyns have several immediate and long-term challenges<...
Article
- Author:
- Robert L. Barbieri, MD
Publish date: May 12, 2022
We are in the midst of a nationwide severe blood product shortage, necessitating that we optimize maternal red blood ...
Article
- Author:
- Robert L. Barbieri, MD
Publish date: April 7, 2022
IUD perforation of the uterus is uncommon, occurring in 0.1% of low-risk patients. IUD expulsion is common, with a ra...
Article
- Author:
- Robert L. Barbieri, MD
Publish date: March 15, 2022
Molecular testing is more sensitive and specific than microscopy for the identification of organisms causing disease....
Article
- Author:
- Robert L. Barbieri, MD
Publish date: February 8, 2022
Among progestin-only contraceptive pills, compared to norethindrone, drospirenone has superior performance on key dim...
Article
- Author:
- Robert L. Barbieri, MD
Publish date: January 10, 2022
Magnesium treatment reduces the risk of seizure in patients with preeclampsia. However, prolonged postpartum magnesium infusion may cause harm, inc...
Article
- Author:
- Robert L. Barbieri, MD
Publish date: December 7, 2021
Patients undergoing cesarean surgery who were previously naïve to opioid medications have a 0.33% to 2.2% probability of transitioning to the persi...
Article
- Author:
- Robert L. Barbieri, MD
Publish date: November 4, 2021
In the United States, 1 in 7 adults has type 2 diabetes mellitus (T2DM), and one-quarter of people with T2DM are undiagnosed. Screening for diabete...
Article
- Author:
- Robert L. Barbieri, MD
Publish date: October 6, 2021
Medical record “note bloat” is adversely impacting communication among clinicians. It is time to refocus on the ABCs of note writing including accu...
Article
- Author:
- Robert L. Barbieri, MD
Publish date: September 9, 2021
Oral relugolix combination therapy (relugolix, estradiol, norethindrone acetate) was effective in controlling excess bleeding caused by uterine fib...
Article
- Author:
- Robert L. Barbieri, MD
Publish date: August 16, 2021
The American Cancer Society now recommends screening for colorectal cancer starting at age 45 years, not 50. The best...
Article
- Author:
- Robert L. Barbieri, MD
Publish date: July 7, 2021
There are 5 different dose combinations of ethinyl estradiol and norethindrone acetate, ranging from 2.5 µg to 30 µg of ethinyl estradiol, and a 6t...
